Johnson & Johnson COVID-19 Vaccine On Pause Because Of Blood Clots

(Cheryl Gerber/Courtesy of Johnson & Johnson via AP)

U.S. health agencies are calling for an immediate pause in using the Johnson & Johnson COVID-19 vaccine because of rare blood clots. The FDA and CDC are recommending a temporary halt to the “one and done” vaccine while they review the data.

Six women between the ages of 18 and 48 developed blood clots a week or two after they were vaccinated. One woman died and another is hospitalized in critical condition.

Texas AG Sues Biden Admin Over Immigration Protocols

Previous article

Minnesota, Oregon Protests Over Police Killing Of Black Man

Next article

You may also like